Abstract:Xi Zhang, 1, &ast Mingming Zhang, 1, &ast Sijun Huang, 1 Kiyoshi Ohtani, 2 Li Xu, 1 Yi Guo 1 1 Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, People's Republic of China; 2 Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, Hyogo, 669-1337, Japan &astThese authors contributed equally to this work Correspondence: Li Xu; Yi Guo, Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, People's Republic of China, Email ; Objective: This study aimed to deliver a polypeptide from the Bax-BH3 domain (BHP) through the synthesis of self-assembled amphiphile nanovectors (NVs) and to assess their potential for cancer therapeutic applications and biological safety in vitro and in vivo. These findings provide valuable options for cancer intervention and a novel approach for the rational design of therapeutics. Methods: We studied the antitumor activity of BHP by preparing RGDfK-PHPMA-b-Poly (MMA- alt -(Rhob-MA)) (RPPMMRA) and encapsulating it in BHP-NV. We also performed a series of characterizations and property analyses of RPPMMRA, including its size, stability, and drug-carrying capacity. The biocompatibility of RPPMMRA was evaluated in terms of cytotoxicity and hemolytic effects. The pro-apoptotic capacity of BHP was evaluated in vitro using mitochondrial membrane potential, flow cytometry, and apoptosis visualization techniques. The potential therapeutic effects of BHP on tumors were explored using reverse molecular docking. We also investigated the in vivo proapoptotic effect of BHP-NV in a nude mouse tumor model. Results: NVs were successfully prepared with hydrated particle sizes ranging from 189.6 nm to 256.6 nm, spherical overall, and were able to remain stable in different media for 72 h with drug loading up to 15.2%. The NVs were be successfully internalized within 6 h with good biocompatibility. Neither BHP nor NV showed significant toxicity when administered alone, however, BHP-NV demonstrated significant side effects in vitro and in vivo. The apoptosis rate increased significantly from 14.13% to 66.34%. Experiments in vivo showed that BHP-NV exhibited significant apoptotic and tumor-suppressive effects. Conclusion: A targeted fluorescent NV with high drug delivery efficiency and sustained release protected the active center of BHP, constituting BHP-NV for targeted delivery. RPPMMRA demonstrated excellent biocompatibility, stability, and drug loading ability, whereas and BHP-NV demonstrated potent antitumor effects in vivo and in vitro. Graphical Keywords: HPMA copolymers, BH3 domain, pro-apoptotic, polypeptide drugs, RGDfK Graphical Cancer is one of the leading causes of death worldwide, with no effective treatments available. 1 Antitumor polypeptides, including both small-molecule (molecular weight <1000) and protein drugs, are a powerful substitute for conventional small-molecule anticancer drugs. 2–4 Since the beginning of the century, peptides have been ideal candidates for alternative therapeutic options due to the urgent demand and their inherently high activity, small dosage, good solubility, excellent safety, uncomplicated synthesis, and modification. 5–11 However, almost all antitumor peptides exhibit low metabolic stability, poor specificity of tumor cells, and poor permeability of tumor tissues and cell membranes. This hinders the application of antitumor peptides in clinical treatment. As the theory of apoptosis becomes clear, the induction of tumor cell apoptosis specifically targeting the apoptotic pathway, can be an effective therapeutic approach. 12 Peptides and their derivatives with apoptosis-inducing functions have gradually become important in the research and development of antitumor agents. BH3 peptides are derived from the Bcl-2 family and their analogs have demonstrated unique apoptotic activation functions. 13–17 In our previous study, we synthesized and evaluated a peptide containing 20 amino acid sequences depending on the Bax-BH3 domain, namely BHP, which could be considered a novel small-molecule anticancer peptide drug. 18 However, BHP is hindered by inefficacious cellular internalization and proteolytic resistance. The design of an appropriate drug carrier to deliver BHP and ensure its uptake by cells is a critic -Abstract Truncated-

Engineered Polymeric Nanovector for Intracellular Peptide Delivery in Antitumor Therapy

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

A Ph‐responsive Nanoparticle Delivery System Containing Dihydralazine and Doxorubicin‐based Prodrug for Enhancing Antitumor Efficacy

Self‐Assembled Bifunctional Peptide As Effective Drug Delivery Vector with Powerful Antitumor Activity

Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex

Activatable Cell Penetrating Peptide-Conjugated Nanoparticles with Enhanced Permeability for Site-Specific Targeting Delivery of Anticancer Drug

Poly(3-hydroxybutyrate- co -3-hydroxyhexanoate) Biopolyester Based Nanoparticles as NVP-BEZ235 Delivery Vehicle for Tumor Targeting Therapy.

Intelligent “ PeptideGathering PeptideGathering PeptideGathering Mechanical Arm ” Tames Wild “ TrojanHorse TrojanHorse TrojanHorse ” Peptides for the Controlled Delivery of Cancer

Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.

Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides

Smart delivery of poly-peptide composite for effective cancer therapy

Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants

Self-assembling branched amphiphilic peptides for targeted delivery of small molecule anticancer drugs

A polymeric nanocarrier with a tumor acidity-activatable arginine-rich (R9) peptide for enhanced drug delivery.

Hydrophilic Poly(Glutamic Acid)-Based Nanodrug Delivery System: Structural Influence and Antitumor Efficacy

A Specific Drug Delivery System for Targeted Accumulation and Tissue Penetration in Prostate Tumors Based on Microbially Synthesized PHBHHx Biopolyester and Irgd Peptide Fused PhaP.

Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response.

Tumor Targeting and Microenvironment-Responsive Multifunctional Fusion Protein for Pro-Apoptotic Peptide Delivery

Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch

The Use of A Hydrophobic Binding Peptide Modified Lipid Nanocarrier Improving Tumor Distribution and Antitumor Efficacy